NCT00230282
- Conditions
- B-cell Leukemia, Chronic Disease, Chronic Leukemia, +16 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
Clinical trial condition
Chronic Lymphocytic Leukemia (CLL)
Explore clinical trials studying Chronic Lymphocytic Leukemia (CLL). Study availability and eligibility vary by location and protocol.
72 public trials
20 recruiting studies
Chronic Lymphocytic Leukemia (CLL) trial results
NCT00919321
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- Tampere University Hospital Tampere, Pirkanmaa, Finland
NCT00458679
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- The Methodist Hospital Houston, Texas, United States
NCT00439231
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic Malignancies
NCT00710528
- Conditions
- Acute Myeloid Leukemia (AML), Blood Protein Disorders, Cardiovascular Diseases, +29 more
- Locations
-
- Stanford Cancer Center Palo Alto, California, United States
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
NCT00640523
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- Tower Cancer Research Foundation Beverly Hills, California, United States
- UCLA Medical Center Los Angeles, California, United States
- Indiana University Cancer Pavillion Indianapolis, Indiana, United States
- Center for Cancer & Blood Disorders, PC Bethesda, Maryland, United States
Active, Not Recruiting
Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
NCT00840853
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +19 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Active, Not Recruiting
Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax
NCT04419519
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +15 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
Active, Not Recruiting
The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)
NCT04447768
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- Stanford University Medical Center (Data collection only) Stanford, California, United States
- Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
Active, Not Recruiting
A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies
NCT03085173
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States